What if you could just ask diabetes business questions in plain English and get instant, reliable answers?
What if that answer was in the form of a chart or graph you could drop directly into a slide deck?
Answers
Introducing
dQ&A AI Insights
Instant, Reliable Insights
Introducing a cutting edge application of AI technology to diabetes and cardio-metabolic market research
dQ&A is announcing a breakthrough application of AI to diabetes and cardio-metabolic market research. Our new AI Insights Platform queries dQ&A’s massive ‘data lake’ of diabetes patient data to deliver instant results.
dQ&A’s AI Insights Platform
- Answers your natural language questions
- Gives instant answers, based on primary market data
- Handles complex queries and takes care of the cross-tabs
- Outputs a visual representation of the data and highlights the insights
- Drops smoothly into your workflow
- Doesn’t ‘generate’ any extra information, only returns reliable primary data
How Does It Work?
We know that Generative AI does a good job of understanding natural language queries.
But it can confidently provide inaccurate answers, because it has no inherent understanding of the information it returns.
dQ&A AI Insights is different.
Our platform is purposely designed to access specific variables in a dataset. It knows what these variables represent. Having identified the correct variables from your question, it can build crosstabs and charts to highlight the insights you need.
It doesn’t generate any data. It just references data from our high quality dataset - so it can’t ‘hallucinate’. And if it can’t locate the right insights from your question, it says “I don’t know”.
Apply For Our Beta Program
How Does It Work?
dQ&A AI pulls insights from our extensive dataset and delivers them in graphical form
About dQ&A Data
dQ&A AI Insights references data from our high-quality dataset
dQ&A Data Lake
Since 2010, dQ&A has collected extensive primary research data on tens of thousands of people with diabetes per year.
dQ&A was founded to faithfully represent the voice of the patient, so we can help create the best possible products and services to improve their quality of life.
Thanks to the generosity of our communities, we’ve collected a massive dataset of the most relevant and valuable information about the lived patient experience.
This is continuous, longitudinal data. We check in with the same people multiple times per year, and they update us on every facet of their life with diabetes. We collect up to 120 points of information from every respondent, which we track over time. The average community member will answer our research questions over the course of many years.
Our Data Lake includes insights about:
- Drugs, Devices, Services Used (both prescription and non-prescription) – covering dozens of brands
- Satisfaction
- Switching behavior and reasons for switching
- Patient Reported Outcomes (like weight, A1c, TIR)
- Relationship with healthcare professionals
The dQ&A Data Lake:
- Covers nine countries (USA, Canada, UK, Germany, France, Italy, Spain, Netherlands, Sweden)
- Is representative of the whole diabetes population across many measures
- Contains a detailed demographic and healthographic census of respondents
- Covers thousands of individual patient journeys
- Includes rich qualitative information in the form of write-in responses
dQ&A AI Insights Availability
Our AI Insights platform is being developed to pair with dQ&A Data Services. Data Services customers will be able to use AI Insights to query their subscription data, to obtain immediate results in a more interactive manner.
Developing the platform has proceeded with a strong focus on quality. In addition to building AI-powered query, analysis and display functionality, we have invested in an extensive suite of QC tests to ensure reliability.
Progress Update
- dQ&A AI Insights is currently in internal Beta. We are using the platform to generate reports, in order to evaluate it in end to end use cases.
- AI Insights will be available in beta form to pre-selected clients in early 2026.
- General Release is expected in 1H 2026.
You’ve Got Questions.
Contact us for more information about dQ&A AI Insights or to request access to our beta program.
